IL-6 is elevated in patients developing IPS. IL-6 levels in plasma from patients at the time of diagnosis of IPS after alloSCT (n = 38), control BMT recipients without evidence of IPS between days 14 and 21 after SCT (control BMT, n = 14) and normal volunteers (n = 13). **P < .01.